Skip to main content

Table 3 Cell lines from ovarian clear cell carcinoma

From: Establishment and characterization of a cell line (HCH-1) originating from a human clear cell carcinoma of the ovary

Cell line Age Materials Chromosome number DT (hour) Transplantability Immunotaining Characteristics
HUOCA-II (1987) 51 Ovary 46 (mode) 24, 28 Yes - Tumor angiogenesis factor
RMG-I (1988) 34 Ascites 47 (mode) 60 Yes BFP, ferritin, PLAP -
OCC1 (1990) 47 Ascites 70–77 36, 38 Yes - Production of CA125
RMG-II (1991) 53 Ascites hypertetraploid 58 No CA125, TPA, MA602-1, MA602-6 Production of CA125, TPA, MA602-1, MA602-6
OVISE (1995) 40 Metastatic tumor 62 (59–65) 60 Yes CA125, CA19-9, EGFR, ER(−), PgR(−) Production of CA19-9, CA125, TPA
OVTOKO (1995) 78 Metastatic tumor 78 (76–83) 70 Yes EGFR, ER(−), PgR(−) -
JHOC-5 (1999) 47 Ovary 74–85 52 No - CA125
JHOC-6 (1999) 43 Recurrent tumor 46–49 70 Yes - CA125
SMOV-2 (1999) 46 Tumor 85–92 48.2 Yes - p53 mutation (−)
TAYA (2002) 43 Ascites 69–74 50 No - p53 Exon5 point mutation, PTEN mutation (−)
RMG-V (2005) 52 ascites 83 (77–85) 15.5 No - -
TU-OC-1 (2013) 65 Ovary 64–69 38.4 Yes - PIK3CA mutation (+)
HCH-1 67 Ovary 39–44 48.7, 66.4 Yes CA125, CA19-9, ER(−), PgR(−) production of CA19-9, CA125, TPA
  1. DT doubling time (hour)